220 related articles for article (PubMed ID: 16375628)
1. The prognostic value of anemia, right-heart catheterization and neurohormones in chronic heart failure.
Gardner RS; McDonagh TA
Expert Rev Cardiovasc Ther; 2006 Jan; 4(1):51-7. PubMed ID: 16375628
[TBL] [Abstract][Full Text] [Related]
2. [Clinical use of markers of neurohormonal activation in heart failure].
Roig Minguell E
Rev Esp Cardiol; 2004 Apr; 57(4):347-56. PubMed ID: 15104989
[TBL] [Abstract][Full Text] [Related]
3. Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure.
Tang WH; Tong W; Jain A; Francis GS; Harris CM; Young JB
J Am Coll Cardiol; 2008 Feb; 51(5):569-76. PubMed ID: 18237687
[TBL] [Abstract][Full Text] [Related]
4. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
5. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
[TBL] [Abstract][Full Text] [Related]
6. Neurohormones in heart failure: predicting outcomes, optimizing care.
Givertz MM; Braunwald E
Eur Heart J; 2004 Feb; 25(4):281-2. PubMed ID: 14984914
[No Abstract] [Full Text] [Related]
7. Prevalence and prognostic significance of elevated gamma-glutamyltransferase in chronic heart failure.
Poelzl G; Eberl C; Achrainer H; Doerler J; Pachinger O; Frick M; Ulmer H
Circ Heart Fail; 2009 Jul; 2(4):294-302. PubMed ID: 19808352
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin, a new prognostic biomarker in patients with chronic heart failure.
Rosenberg M; Zugck C; Nelles M; Juenger C; Frank D; Remppis A; Giannitsis E; Katus HA; Frey N
Circ Heart Fail; 2008 May; 1(1):43-9. PubMed ID: 19808269
[TBL] [Abstract][Full Text] [Related]
9. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
[TBL] [Abstract][Full Text] [Related]
10. [Practice guidelines for patients with chronic heart failure].
Matsuzaki M; Okusa T
Nihon Naika Gakkai Zasshi; 2002 Mar; 91(3):973-90. PubMed ID: 11985111
[No Abstract] [Full Text] [Related]
11. Prevalence of anemia in heart failure and its effects on prognosis.
Belziti CA
Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):131-8. PubMed ID: 19210209
[TBL] [Abstract][Full Text] [Related]
12. Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure.
Schou M; Gustafsson F; Kistorp CN; Corell P; Kjaer A; Hildebrandt PR
Am J Cardiol; 2007 Nov; 100(10):1571-6. PubMed ID: 17996522
[TBL] [Abstract][Full Text] [Related]
13. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
[TBL] [Abstract][Full Text] [Related]
14. Neurohormonal and inflammatory markers as predictors of short-term outcome in patients with heart failure and cardiac resynchronization therapy.
Glick A; Michowitz Y; Keren G; George J
Isr Med Assoc J; 2006 Jun; 8(6):391-5. PubMed ID: 16833167
[TBL] [Abstract][Full Text] [Related]
15. The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET.
Komajda M; Anker SD; Charlesworth A; Okonko D; Metra M; Di Lenarda A; Remme W; Moullet C; Swedberg K; Cleland JG; Poole-Wilson PA
Eur Heart J; 2006 Jun; 27(12):1440-6. PubMed ID: 16717081
[TBL] [Abstract][Full Text] [Related]
16. Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy.
Pires LA
Curr Opin Anaesthesiol; 2006 Feb; 19(1):69-74. PubMed ID: 16547436
[TBL] [Abstract][Full Text] [Related]
17. Red cell distribution width in chronic heart failure: a new independent marker for prognosis?
Hammarsten O; Jacobsson S; Fu M
Eur J Heart Fail; 2010 Mar; 12(3):213-4. PubMed ID: 20156935
[No Abstract] [Full Text] [Related]
18. Correlation between sTNFR-I and other negative prognostic factors in patients with chronic heart failure.
Pop D; Zdrenghea D; Cebanu M; Borz B
Rom J Intern Med; 2007; 45(3):243-9. PubMed ID: 18333356
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic value of discharge hemoglobin level in patients hospitalized for acute heart failure].
Sánchez-Torrijos J; Gudín-Uriel M; Nadal-Barangé M; Jacas-Osborn V; Trigo-Bautista A; Giménez-Alcalá M; Payá-Serrano R; Ridocci-Soriano F
Rev Esp Cardiol; 2006 Dec; 59(12):1276-82. PubMed ID: 17194423
[TBL] [Abstract][Full Text] [Related]
20. Anemia in heart failure.
Kılıçgedik A; Dündar C; Tigen MK
Anadolu Kardiyol Derg; 2012 Feb; 12(1):65-70. PubMed ID: 22214745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
